Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000291848 | SCV000431934 | uncertain significance | Alstrom syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000291848 | SCV003826174 | uncertain significance | Alstrom syndrome | 2022-03-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003392209 | SCV004119550 | uncertain significance | ALMS1-related disorder | 2023-09-01 | criteria provided, single submitter | clinical testing | The ALMS1 c.10829A>G variant is predicted to result in the amino acid substitution p.Gln3610Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.039% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-73799836-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |